Bogunia-Kubik K, Lange A
L. Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, Poland.
Int J Immunogenet. 2008 Aug;35(4-5):409-16. doi: 10.1111/j.1744-313X.2008.00789.x.
In order to increase the reliability of histocompatibility testing, several external proficiency testing (EPT) schemes have been established within Europe. All the laboratories trying to obtain European Federation for Immunogenetics (EFI) accreditation are obliged to take part in standardization trials for human leucocyte antigen (HLA) typing and to participate in EPT programme(s) to cover all techniques in use for accredited activities. We started our activity in 1999. At that time, the Quality Control Workshop was run for Polish laboratories involved in HLA typing. A year later, our activity was expanded to the Central East European area. As a result, the third national workshop was combined with the Proficiency Testing of HLA Class I Typing for Central and East Europe. In total, until year 2005, 38 institutions from 14 countries have participated in our workshop. During that period the results of HLA class I A, B and C locus typing by serology and at the DNA low resolution level were expected. To meet the further requirements of participating laboratories starting with year 2006 and the XI trial of the workshop we plan to increase the number of HLA loci to be tested (HLA class II DRB1 and DQB1) and include also high resolution typing. Our EPT is organized under the auspices of the Polish Society for Immunogenetics (PSI) and all laboratories within Poland involved in HLA typing for donor selection within Poltransplant and seeking the PSI accreditation are obliged to participate in our workshop.
为提高组织相容性检测的可靠性,欧洲已建立了多个外部能力验证(EPT)计划。所有试图获得欧洲免疫遗传学联合会(EFI)认可的实验室都必须参加人类白细胞抗原(HLA)分型的标准化试验,并参与EPT计划,以涵盖认可活动中使用的所有技术。我们于1999年开始开展活动。当时,为参与HLA分型的波兰实验室举办了质量控制研讨会。一年后,我们的活动扩展到中东欧地区。结果,第三届全国研讨会与中东欧HLA I类分型能力验证合并。截至2005年,共有来自14个国家的38个机构参加了我们的研讨会。在此期间,需要通过血清学和DNA低分辨率水平对HLA I类A、B和C位点进行分型的结果。为满足从2006年开始参与实验室的进一步要求以及研讨会的第十一次试验,我们计划增加待检测的HLA位点数量(HLA II类DRB1和DQB1),并包括高分辨率分型。我们的EPT在波兰免疫遗传学协会(PSI)的支持下组织,波兰境内所有参与Poltransplant内供体选择的HLA分型并寻求PSI认可的实验室都必须参加我们的研讨会。